yhteisvaikutukset

name

• yhteisvaikutukset

Works about yhteisvaikutukset

• Antiepileptic drug treatment in the elderly : choice of initial treatment, potential interactions and seizure outcome
• Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
• Clozapine : clinical studies on adverse effects and interactions
• Cytochrome P450-mediated drug interactions affecting lidocaine
• Drug epidemiology, interactions and pharmacogenetics :
• Drug use among the home-dwelling elderly : trends, polypharmacy, and sedation
• Drug use and polypharmacy in elderly persons
• Effect of cytochrome P450 2D6 and 3A enzyme inhibition on the metabolism of oxycodone
• Effects of cytochrome P450 enzyme inhibitors and inducers on the metabolism of S-ketamine
• Effects of cytochrome P450 enzyme inhibitors on the metabolism of drugs used in anaesthesiology
• Effects of cytochrome P450 enzyme inhibitors on the pharmacokinetics of nonsteroidal anti-inflammatory drugs and venlafaxine
• Effects of drug interactions and liver disease on the pharmacokinetics of ropivacaine
• Effects of gemfibrozil and rifampicin on the pharmacokinetics of HMG-CoA reductase inhibitors
• Effects of induction and inhibition of cytochrome P-450 enzymes on the pharmacokinetics and pharmacodynamics of oral antidiabetic drugs
• Epidemiology of cytochrome P450-mediated drug-drug interactions
• Immunotoxic responses induced by Streptomyces californicus and Stachybotrys chartarum : the role of microbial interactions
• In vitro and in silico methods to predict cytochrome P450 enzyme inhibition
• Inhibition of CYP1A2-mediated drug metabolism in vitro and in humans : with special emphasis on rofecoxib and other NSAIDs
• Integrating mechanistic disturbance models and stand dynamics of Norway spruce
• Interactions of tizanidine with CYP1A2 enzyme inhibitors : studies in vitro and in humans
• Interventiotutkimus oppilaiden motoristen taitojen ja lukutaidon kehittymisestä sekä niiden välisistä yhteyksistä ensimmäisen kouluvuoden aikana
• Iäkkäiden lääkehoito
• Iäkkäiden lääkehoito :
• Joint effects of infections with different types of human papillomavirus on risk of cervical neoplasia
• Kasviravintolisien riskiprofiili
• Kokemuksia sähköisen reseptin käyttöönoton vaikutuksista Suomessa : tutkimus lääkäreiden, farmaseuttien ja proviisorien näkökulmasta
• Lääkkeiden yhteisvaikutukset
• Me, ikääntyminen ja lääkkeet
• Mechanism-based inhibition of CYP2C8 by gemfibrozil in humans : characterisation of time and dose relationships
• Melu, työn fyysinen rasittavuus ja vuorotyö sekä metabolinen oireyhtymä : erillis- ja yhteisvaikutukset sepelvaltimotaudin vaaraan
• Offspring of mothers with psychotic disorder : childhood development and adulthood psychiatric morbidity
• On the environmental genetics of depressive symptoms: focus on two serotonergic genes
• Outer space influence on the low and middle polar atmosphere
• Perspectives on alcohol consumption in older adults
• Perspectives on prescribing in nursing homes in Helsinki
• Pharmacokinetic interactions affecting the antidiabetic repaglinide
• Pharmacokinetic interactions and pharmacogenetics of aliskiren
• Pharmacokinetic interactions of clozapine in hospitalized patients
• Pharmacokinetics of montelukast and zafirlukast as affected by CYP inhibitors
• Potential metabolism-based drug interactions with isoquinoline alkaloids :
• Ravitsemus apteekkityössä
• Removal of viruses from drinking water by chlorine and UV disinfections
• Role of CYP2C8 in the metabolism of montelukast and imatinib : Studies in vitro, in silico and in humans
• Sopimusten välinen liityntä ja päättymisen vaikutus
• Strategies to enhance efficacy of oncolytic virotherapy
• Studies on CYP2C8-mediated drug interactions
• Syöpälääkkeet
• The effect of systemically and locally administered clodronate on bone quality
• The role of cytochrome P450 3A inducers and inhibitors in the metabolism and the effects of oxycodone
• Unohdetut ympäristöongelmat
• Vi äldre människor och våra mediciner
• Ympäristöatlas